Skip to main content

Table 3 Comparison of PRO prioritization at study conclusion (m3) by condition, weighted rank mean score (standard deviation)

From: Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower

  All (N = 140) RA (n = 56) PsA (n = 28) OA (n = 19) AS (n = 18) FMS (n = 15) SLE (n = 4)
PROMIS Fatigue* 39.2 (35.6) 50.0 (37.3) 33.9 (30.2) 21.1 (32.6) 33.8 (31.6) 36.7 (37.2) 43.8 (42.7)
PROMIS Physical Function 29.5 (33.8) 26.6 (33.2) 38.1 (41.0) 28.9 (27.6) 25.6 (33.3) 25.2 (27.9) 45.8 (41.7)
PROMIS Pain Intensity 29.1 (39.4) 23.3 (37.2) 39.4 (42.0) 34.4 (39.3) 31.4 (44.5) 29.7 (39.3) 0 (0)
PROMIS Pain Interference 28.2 (36.4) 25.1 (33.3) 19.8 (33.0) 34.2 (43.5) 39.5 (38.4) 33.0 (39.8) 33.3 (47.1)
Duration of Morning Joint Stiffness 21.1 (31.6) 19.2 (30.1) 18.8 (28.7) 28.6 (35.4) 19.0 (32.2) 24.7 (35.0) 25.0 (50.0)
PROMIS Sleep Disturbance 20.1 (26.7) 24.3 (30.0) 21.0 (24.4) 16.4 (27.0) 16.6 (27.2) 11.9 (18.9) 19.6 (14.2)
PROMIS Applied Cognition Abilities 10.7 (22.4) 12.6 (23.7) 9.6 (20.7) 3.5 (10.5) 15.8 (26.9) 11.3 (28.0) 0 (0)
PROMIS Depression 9.9 (20.5) 8.0 (18.0) 7.9 (13.9) 20.3 (31.4) 6.9 (14.4) 13.6 (28.4) 0 (0)
  1. Participants ranked their first through fifth choice by importance, considering all PROs they had selected during the 3-month study; ranking was done only by participants who completed the study; weighted rank mean scores for participants’ ranking of each PRO were generated by using weighted individual participant rankings multiplied by 100, then taking the mean of participants’ rankings for each PRO; PROs unranked by participants carried a zero value for inclusion in mean ranking score calculation; range of possible scores 0–100
  2. *Statistical significance (p < 0.05) from ANOVA to compare mean PRO ranking scores overall across conditions